Appendix cancer diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:


=== Study of choice ===
=== Study of choice ===
CT-scan/MRI are diagnostic study of choice for appendix cancer.  PCI using either CT-scan or preferably diffusion weighted MRI has been recommended to determine disease burden.
CT-scan/MRI are diagnostic study of choice for appendix cancer.  Peritoneal carcinomatosis index (PCI) using either '''CT-scan''' or preferably '''diffusion weighted MRI''' has been recommended to determine disease burden.


Histopathology is the gold standard test for the diagnosis of appendix cancer.
Histopathology is the gold standard test for the diagnosis of appendix cancer.
Line 19: Line 19:
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most sensitive test for diagnosis.
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most sensitive test for diagnosis.
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most efficient test for diagnosis.
* Among the patients who present with clinical signs of [disease name], the [investigation name] is the most efficient test for diagnosis.
-----------------------------------------------
*'''''Peritoneal carcinomatosis index (PCI):''' a widely accepted metric for assessment of disease border in appendix cancer''<ref name="pmid8849962">Jacquet P, Sugarbaker PH (1996) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=8849962 Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.] ''Cancer Treat Res'' 82 ():359-74. PMID: [https://pubmed.gov/8849962 8849962]</ref>
** Estimated by contrast enhanced cross sectional imaging.
** Both MRI and CT scan has been used and are globally accepted imaging modalities.
** Small peritoneal seeding might be difficult to appreciate on CT.
** Sometimes it is challenging to distinguish between tumor and mucin.
** There are reports in favor of diffusion weighted MRI superiority compared to CT in evaluating extent of peritoneal involvement.<ref name="pmid22302265">Low RN, Barone RM (2012) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=22302265 Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures.] ''Ann Surg Oncol'' 19 (5):1394-1401. [http://dx.doi.org/10.1245/s10434-012-2236-3 DOI:10.1245/s10434-012-2236-3] PMID: [https://pubmed.gov/22302265 22302265]</ref>
**'''''Table and figure below demonstrate abdominal regions as well as scoring system for PCI.'''''
[[Image:Peritoneal Carcinomatosis Index (PCI) Regions.jpg|thumb|left|'''Peritoneal Carcinomatosis Index (PCI) Regions'''|400px|right|Peritoneal Carcinomatosis Index (PCI) Regions]]
{| class="wikitable"
|+PCI Scoring System
! colspan="2" |Lesion Size Score
|-
|LS0
|No tumor seen
|-
|LS1
|Tumor up to 0.5 cm
|-
|LS2
|Tumor up to 5 cm cm
|-
|LS3
|Tumor > 5 cm or confluence
|-
| colspan="2" |''Maximum Score = 3''
|-
! colspan="2" |Regions (0-3)
|-
|0
|Central
|-
|1
|Right Upper
|-
|2
|Epigasterium
|-
|3
|Left Upper
|-
|4
|Left Flank
|-
|5
|Left Lower
|-
|6
|Pelvis
|-
|7
|Right Upper
|-
|8
|Right Flank
|-
|9
|Upper Jejunum
|-
|10
|Lower Jejunum
|-
|11
|Upper Illeum
|-
|12
|lower Illeum
|-
| colspan="2" |''Maximum Score = 36''
|-
| colspan="2" |'''Total Maximum Score = 39'''
|}


==== The comparison of various diagnostic studies for [disease name] ====
==== The comparison of various diagnostic studies for [disease name] ====

Revision as of 19:29, 25 January 2019

Appendix cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Differentiating Appendix cancer from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

MRI

CT scan

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Appendix cancer diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Appendix cancer diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Appendix cancer diagnostic study of choice

CDC on Appendix cancer diagnostic study of choice

Appendix cancer diagnostic study of choice in the news

Blogs on Appendix cancer diagnostic study of choice

Directions to Hospitals Treating Appendix cancer

Risk calculators and risk factors for Appendix cancer diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Overview

Either CT-scan or MRI are diagnostic study of choice for appendix cancer.

Histopathology is the gold standard test for the diagnosis of appendix cancer.

Diagnostic Study of Choice

Study of choice

CT-scan/MRI are diagnostic study of choice for appendix cancer. Peritoneal carcinomatosis index (PCI) using either CT-scan or preferably diffusion weighted MRI has been recommended to determine disease burden.

Histopathology is the gold standard test for the diagnosis of appendix cancer.

Investigations:

  • Among the patients who present with clinical signs of [disease name], the [investigation name] is the most specific test for the diagnosis.
  • Among the patients who present with clinical signs of [disease name], the [investigation name] is the most sensitive test for diagnosis.
  • Among the patients who present with clinical signs of [disease name], the [investigation name] is the most efficient test for diagnosis.

  • Peritoneal carcinomatosis index (PCI): a widely accepted metric for assessment of disease border in appendix cancer[1]
    • Estimated by contrast enhanced cross sectional imaging.
    • Both MRI and CT scan has been used and are globally accepted imaging modalities.
    • Small peritoneal seeding might be difficult to appreciate on CT.
    • Sometimes it is challenging to distinguish between tumor and mucin.
    • There are reports in favor of diffusion weighted MRI superiority compared to CT in evaluating extent of peritoneal involvement.[2]
    • Table and figure below demonstrate abdominal regions as well as scoring system for PCI.
Peritoneal Carcinomatosis Index (PCI) Regions
PCI Scoring System
Lesion Size Score
LS0 No tumor seen
LS1 Tumor up to 0.5 cm
LS2 Tumor up to 5 cm cm
LS3 Tumor > 5 cm or confluence
Maximum Score = 3
Regions (0-3)
0 Central
1 Right Upper
2 Epigasterium
3 Left Upper
4 Left Flank
5 Left Lower
6 Pelvis
7 Right Upper
8 Right Flank
9 Upper Jejunum
10 Lower Jejunum
11 Upper Illeum
12 lower Illeum
Maximum Score = 36
Total Maximum Score = 39



The comparison of various diagnostic studies for [disease name]

Test Sensitivity Specificity
Test 1 ...% ...%
Test 2 ...% ...%

[Name of test with higher sensitivity and specificity] is the preferred investigation based on the sensitivity and specificity

Diagnostic results

The following finding(s) on performing [investigation name] is(are) confirmatory for [disease name]:

  • [Finding 1]
  • [Finding 2]
Sequence of Diagnostic Studies

The [name of investigation] must be performed when:

  • The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
  • A positive [test] is detected in the patient, to confirm the diagnosis.

OR

The various investigations must be performed in the following order:

  • [Initial investigation]
  • [2nd investigation]

Name of Diagnostic Criteria

It is recommended that you include the criteria in a table. Make sure you always cite the source of the content and whether the table has been adapted from another source.

[Disease name] is primarily diagnosed based on clinical presentation. There are no established criteria for the diagnosis of [disease name].

OR

There is no single diagnostic study of choice for [disease name], though [disease name] may be diagnosed based on [name of criteria] established by [...].

OR

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

[Disease name] may be diagnosed at any time if one or more of the following criteria are met:

  • Criteria 1
  • Criteria 2
  • Criteria 3

OR

IF there are clear, established diagnostic criteria

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].

OR

The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

IF there are no established diagnostic criteria

There are no established criteria for the diagnosis of [disease name].

References

Template:WH Template:WS